Cited by 56Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Health and Risk FactorsSmoking Behavior and Cessation

Risk of Smoking and Metabolic Syndrome for Incidence of Cardiovascular Disease Comparison of Relative Contribution in Urban Japanese Population: The Suita Study

Open access
Higashiyama, Aya, Okamura, Tomonori, Ono, Yuu, Watanabe, Makoto, Kokubo, Yoshihiro, Okayama, Akira·2009·Circulation Journal

Abstract

BACKGROUND: Risk factor clustering, the so-called metabolic syndrome (MetS), is an important risk factor for cardiovascular disease (CVD). Smoking is also an important CVD risk factor with still a high prevalence. However, few previous studies have compared the risk for CVD or the population-attributable fraction (PAF) of smoking, MetS, and both. METHODS AND RESULTS: The present study was an 11.9-year cohort study of 1,822 men and 2,089 women, aged 40-74 years, selected randomly from an urban general population in Japan. MetS was defined according to the National Cholesterol Education Program on Adult Treatment Panel III (NCEP-ATPIII) guideline modified by the Asian criteria for waist circumference. The prevalence of smoking was 49.5% in men and 11.1% in women, and that of MetS was 19.8% and 23.5%, respectively. In men, the multivariate-adjusted hazard ratio for CVD incidence, compared with non-smoking participants without MetS, was 2.07 (1.26-3.40) in those who smoked, 2.09 (1.08-4.04) in those with MetS, and 3.56 (1.89-6.72) in those with both. In men the PAF for CVD incidence was 21.8% because of smoking, 7.5% because of MetS, and 11.9% because of both. CONCLUSIONS: Although countermeasures for MetS are important, smoking should continue to be considered an important public health problem and antismoking campaigns should be promoted, especially for men, to prevent CVD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1253/circj.cj-09-0264

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 30 · Cited by 56

Research works printed but not linked: 3

  1. Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Definition and diagnostic standard for metabolic syndrome. Nippon Naika Gakkai Zasshi 2005; 94: 794 -809 (in Japanese).
  2. Health and Welfare Statistics Association. 2008 Kokumin Eisei No Doko (Trend for National Health and Hygiene, Japan). J Health Welf Stat 2008; 55: 83 (in Japanese).
  3. Imai E, Horio M. Epidemiology of chronic kidney disease: The dif- ference between Japan and Western countries. J Blood Press 2006; 13: 359 -363 (in Japanese).

Authors
Higashiyama, A., Okamura, T., Ono, Y., Watanabe, M., Kokubo, Y., & Okayama, A.
Affiliations
  • Department of Preventive Cardiology, National Cardiovascular Center
  • Japan Anti Tuberculosis Association (JP)
Venue
Circulation Journal
Published
2009
Volume
73
Issue
12
Pages
2258-2263
ISSN
  • 1346-9843 (ISSN-L)
  • 1347-4820
OpenAlex
W1973979669
Cited by
56
References
30
Citations by year
2025: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 5 · 2019: 4 · 2018: 7 · 2017: 3 · 2016: 5 · 2014: 6 · 2013: 5 · 2012: 2
FWCI
3.39
Type
journal article
Language
en
Open access
Locations
  • Circulation Journal (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
Keywords
smoking, metabolic syndrome, cardiovascular disease incidence, population attributable fraction, risk factor clustering, sex differences, anti-smoking campaigns, cardiovascular risk
MeSH terms
Adult, Aged, Cardiovascular Diseases, Female, Follow-Up Studies, Health Surveys, Humans, Japan, Male, Middle Aged, Risk Factors, Sex Factors, Smoking, Urban Health, Incidence, Chi-Square Distribution, Proportional Hazards Models, Risk Assessment, Metabolic Syndrome, Asian People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review